Lv1
50 积分 2025-12-02 加入
Emerging small-molecule inhibitors of the Bruton's tyrosine kinase (BTK): Current development
4个月前
已完结
Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial
4个月前
已完结
Defining a Hodgkin lymphoma population for novel therapeutics after relapse from autologous hematopoietic cell transplant
4个月前
已完结
Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial
4个月前
已完结
皖公网安备34019202002308
